Global and China Translational Regenerative Medicine Market Insights, Forecast to 2027

Publisher Name :
Date: 30-Nov-2021
No. of pages: 141
Inquire Before Buying

Translational Regenerative Medicine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Translational Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Translational Regenerative Medicine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- Stem Cell Therapy

- Tissue Engineering

- Gene Therapy

Segment by Application

- Tissue Engineering Therapy

- Wound Healing

- Cartilage Repair

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Athersys

- Avita Medical

- AxoGen

- MEDIPOST

- NuVasive

- Astellas Pharma

- Organogenesis Holdings

- Osiris Therapeutics

- Pharmicell

- Regenerys

- Takeda Pharmaceutical

- uniQure

- Vericel

Global and China Translational Regenerative Medicine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Translational Regenerative Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Translational Regenerative Medicine Market Size Growth Rate by Type
1.2.2 Stem Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Gene Therapy
1.3 Market by Application
1.3.1 Global Translational Regenerative Medicine Market Size Growth Rate by Application
1.3.2 Tissue Engineering Therapy
1.3.3 Wound Healing
1.3.4 Cartilage Repair
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Translational Regenerative Medicine Market Size, Estimates and Forecasts
2.1.1 Global Translational Regenerative Medicine Revenue 2016-2027
2.1.2 Global Translational Regenerative Medicine Sales 2016-2027
2.2 Global Translational Regenerative Medicine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Translational Regenerative Medicine Historical Market Size by Region (2016-2021)
2.3.1 Global Translational Regenerative Medicine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Translational Regenerative Medicine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Translational Regenerative Medicine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Translational Regenerative Medicine Sales Forecast by Region (2022-2027)
2.4.2 Global Translational Regenerative Medicine Revenue Forecast by Region (2022-2027)
3 Global Translational Regenerative Medicine Competitor Landscape by Players
3.1 Global Top Translational Regenerative Medicine Manufacturers by Sales
3.1.1 Global Translational Regenerative Medicine Sales by Manufacturer (2016-2021)
3.1.2 Global Translational Regenerative Medicine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Translational Regenerative Medicine Manufacturers by Revenue
3.2.1 Key Translational Regenerative Medicine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Translational Regenerative Medicine Revenue by Manufacturers (2016-2021)
3.2.3 Global Translational Regenerative Medicine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Translational Regenerative Medicine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Translational Regenerative Medicine Revenue in 2020
3.2.6 Global Translational Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Translational Regenerative Medicine Price by Manufacturers
3.4 Global Translational Regenerative Medicine Manufacturing Base Distribution, Product Types
3.4.1 Translational Regenerative Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Translational Regenerative Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Translational Regenerative Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Translational Regenerative Medicine Market Size by Type (2016-2021)
4.1.1 Global Translational Regenerative Medicine Sales by Type (2016-2021)
4.1.2 Global Translational Regenerative Medicine Revenue by Type (2016-2021)
4.1.3 Translational Regenerative Medicine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Translational Regenerative Medicine Market Size Forecast by Type (2022-2027)
4.2.1 Global Translational Regenerative Medicine Sales Forecast by Type (2022-2027)
4.2.2 Global Translational Regenerative Medicine Revenue Forecast by Type (2022-2027)
4.2.3 Translational Regenerative Medicine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Translational Regenerative Medicine Market Size by Application (2016-2021)
5.1.1 Global Translational Regenerative Medicine Sales by Application (2016-2021)
5.1.2 Global Translational Regenerative Medicine Revenue by Application (2016-2021)
5.1.3 Translational Regenerative Medicine Price by Application (2016-2021)
5.2 Translational Regenerative Medicine Market Size Forecast by Application (2022-2027)
5.2.1 Global Translational Regenerative Medicine Sales Forecast by Application (2022-2027)
5.2.2 Global Translational Regenerative Medicine Revenue Forecast by Application (2022-2027)
5.2.3 Global Translational Regenerative Medicine Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Translational Regenerative Medicine Market Size YoY Growth 2016-2027
6.1.1 China Translational Regenerative Medicine Sales YoY Growth 2016-2027
6.1.2 China Translational Regenerative Medicine Revenue YoY Growth 2016-2027
6.1.3 China Translational Regenerative Medicine Market Share in Global Market 2016-2027
6.2 China Translational Regenerative Medicine Market Size by Players (International and Local Players)
6.2.1 China Top Translational Regenerative Medicine Players by Sales (2016-2021)
6.2.2 China Top Translational Regenerative Medicine Players by Revenue (2016-2021)
6.3 China Translational Regenerative Medicine Historic Market Review by Type (2016-2021)
6.3.1 China Translational Regenerative Medicine Sales Market Share by Type (2016-2021)
6.3.2 China Translational Regenerative Medicine Revenue Market Share by Type (2016-2021)
6.3.3 China Translational Regenerative Medicine Price by Type (2016-2021)
6.4 China Translational Regenerative Medicine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Translational Regenerative Medicine Sales Forecast by Type (2022-2027)
6.4.2 China Translational Regenerative Medicine Revenue Forecast by Type (2022-2027)
6.4.3 China Translational Regenerative Medicine Price Forecast by Type (2022-2027)
6.5 China Translational Regenerative Medicine Historic Market Review by Application (2016-2021)
6.5.1 China Translational Regenerative Medicine Sales Market Share by Application (2016-2021)
6.5.2 China Translational Regenerative Medicine Revenue Market Share by Application (2016-2021)
6.5.3 China Translational Regenerative Medicine Price by Application (2016-2021)
6.6 China Translational Regenerative Medicine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Translational Regenerative Medicine Sales Forecast by Application (2022-2027)
6.6.2 China Translational Regenerative Medicine Revenue Forecast by Application (2022-2027)
6.6.3 China Translational Regenerative Medicine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Translational Regenerative Medicine Market Size YoY Growth 2016-2027
7.2 North America Translational Regenerative Medicine Market Facts & Figures by Country
7.2.1 North America Translational Regenerative Medicine Sales by Country (2016-2021)
7.2.2 North America Translational Regenerative Medicine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Translational Regenerative Medicine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Translational Regenerative Medicine Market Facts & Figures by Region
8.2.1 Asia Pacific Translational Regenerative Medicine Sales by Region (2016-2021)
8.2.2 Asia Pacific Translational Regenerative Medicine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Translational Regenerative Medicine Market Size YoY Growth 2016-2027
9.2 Europe Translational Regenerative Medicine Market Facts & Figures by Country
9.2.1 Europe Translational Regenerative Medicine Sales by Country (2016-2021)
9.2.2 Europe Translational Regenerative Medicine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Translational Regenerative Medicine Market Size YoY Growth 2016-2027
10.2 Latin America Translational Regenerative Medicine Market Facts & Figures by Country
10.2.1 Latin America Translational Regenerative Medicine Sales by Country (2016-2021)
10.2.2 Latin America Translational Regenerative Medicine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Translational Regenerative Medicine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Translational Regenerative Medicine Market Facts & Figures by Country
11.2.1 Middle East and Africa Translational Regenerative Medicine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Translational Regenerative Medicine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Athersys
12.1.1 Athersys Corporation Information
12.1.2 Athersys Description and Business Overview
12.1.3 Athersys Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Athersys Translational Regenerative Medicine Products Offered
12.1.5 Athersys Recent Development
12.2 Avita Medical
12.2.1 Avita Medical Corporation Information
12.2.2 Avita Medical Description and Business Overview
12.2.3 Avita Medical Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Avita Medical Translational Regenerative Medicine Products Offered
12.2.5 Avita Medical Recent Development
12.3 AxoGen
12.3.1 AxoGen Corporation Information
12.3.2 AxoGen Description and Business Overview
12.3.3 AxoGen Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 AxoGen Translational Regenerative Medicine Products Offered
12.3.5 AxoGen Recent Development
12.4 MEDIPOST
12.4.1 MEDIPOST Corporation Information
12.4.2 MEDIPOST Description and Business Overview
12.4.3 MEDIPOST Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 MEDIPOST Translational Regenerative Medicine Products Offered
12.4.5 MEDIPOST Recent Development
12.5 NuVasive
12.5.1 NuVasive Corporation Information
12.5.2 NuVasive Description and Business Overview
12.5.3 NuVasive Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 NuVasive Translational Regenerative Medicine Products Offered
12.5.5 NuVasive Recent Development
12.6 Astellas Pharma
12.6.1 Astellas Pharma Corporation Information
12.6.2 Astellas Pharma Description and Business Overview
12.6.3 Astellas Pharma Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Astellas Pharma Translational Regenerative Medicine Products Offered
12.6.5 Astellas Pharma Recent Development
12.7 Organogenesis Holdings
12.7.1 Organogenesis Holdings Corporation Information
12.7.2 Organogenesis Holdings Description and Business Overview
12.7.3 Organogenesis Holdings Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Organogenesis Holdings Translational Regenerative Medicine Products Offered
12.7.5 Organogenesis Holdings Recent Development
12.8 Osiris Therapeutics
12.8.1 Osiris Therapeutics Corporation Information
12.8.2 Osiris Therapeutics Description and Business Overview
12.8.3 Osiris Therapeutics Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Osiris Therapeutics Translational Regenerative Medicine Products Offered
12.8.5 Osiris Therapeutics Recent Development
12.9 Pharmicell
12.9.1 Pharmicell Corporation Information
12.9.2 Pharmicell Description and Business Overview
12.9.3 Pharmicell Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pharmicell Translational Regenerative Medicine Products Offered
12.9.5 Pharmicell Recent Development
12.10 Regenerys
12.10.1 Regenerys Corporation Information
12.10.2 Regenerys Description and Business Overview
12.10.3 Regenerys Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Regenerys Translational Regenerative Medicine Products Offered
12.10.5 Regenerys Recent Development
12.11 Athersys
12.11.1 Athersys Corporation Information
12.11.2 Athersys Description and Business Overview
12.11.3 Athersys Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Athersys Translational Regenerative Medicine Products Offered
12.11.5 Athersys Recent Development
12.12 uniQure
12.12.1 uniQure Corporation Information
12.12.2 uniQure Description and Business Overview
12.12.3 uniQure Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 uniQure Products Offered
12.12.5 uniQure Recent Development
12.13 Vericel
12.13.1 Vericel Corporation Information
12.13.2 Vericel Description and Business Overview
12.13.3 Vericel Translational Regenerative Medicine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Vericel Products Offered
12.13.5 Vericel Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Translational Regenerative Medicine Industry Trends
13.2 Translational Regenerative Medicine Market Drivers
13.3 Translational Regenerative Medicine Market Challenges
13.4 Translational Regenerative Medicine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Translational Regenerative Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Translational Regenerative Medicine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Stem Cell Therapy
Table 3. Major Manufacturers of Tissue Engineering
Table 4. Major Manufacturers of Gene Therapy
Table 5. Global Translational Regenerative Medicine Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Translational Regenerative Medicine Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Translational Regenerative Medicine Sales by Regions (2016-2021) & (K Units)
Table 8. Global Translational Regenerative Medicine Sales Market Share by Regions (2016-2021)
Table 9. Global Translational Regenerative Medicine Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Translational Regenerative Medicine Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Translational Regenerative Medicine Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Translational Regenerative Medicine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Translational Regenerative Medicine Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Translational Regenerative Medicine Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Translational Regenerative Medicine Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Translational Regenerative Medicine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Translational Regenerative Medicine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Translational Regenerative Medicine Revenue Share by Manufacturers (2016-2021)
Table 19. Global Translational Regenerative Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Translational Regenerative Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Translational Regenerative Medicine as of 2020)
Table 21. Key Manufacturers Translational Regenerative Medicine Price (2016-2021) (USD/Unit)
Table 22. Translational Regenerative Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Translational Regenerative Medicine Product Type
Table 24. Date of International Manufacturers Enter into Translational Regenerative Medicine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Translational Regenerative Medicine Sales by Type (2016-2021) (K Units)
Table 27. Global Translational Regenerative Medicine Sales Share by Type (2016-2021)
Table 28. Global Translational Regenerative Medicine Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Translational Regenerative Medicine Revenue Share by Type (2016-2021)
Table 30. Translational Regenerative Medicine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 31. Global Translational Regenerative Medicine Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Translational Regenerative Medicine Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Translational Regenerative Medicine Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Translational Regenerative Medicine Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Translational Regenerative Medicine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Translational Regenerative Medicine Sales by Application (2016-2021) (K Units)
Table 37. Global Translational Regenerative Medicine Sales Share by Application (2016-2021)
Table 38. Global Translational Regenerative Medicine Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Translational Regenerative Medicine Revenue Share by Application (2016-2021)
Table 40. Translational Regenerative Medicine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 41. Global Translational Regenerative Medicine Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Translational Regenerative Medicine Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Translational Regenerative Medicine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Translational Regenerative Medicine Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Translational Regenerative Medicine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 46. China Translational Regenerative Medicine Sales (K Units) of Key Companies (2016-2021)
Table 47. China Translational Regenerative Medicine Sales Share by Company (2016-2021)
Table 48. China Translational Regenerative Medicine Revenue (US$ Million) by Company (2016-2021)
Table 49. China Translational Regenerative Medicine Revenue Share by Company (2016-2021)
Table 50. China Translational Regenerative Medicine Sales (K Units) by Type (2016-2021)
Table 51. China Translational Regenerative Medicine Sales Share by Type (2016-2021)
Table 52. China Translational Regenerative Medicine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Translational Regenerative Medicine Price (USD/Unit) by Type (2016-2021)
Table 54. China Translational Regenerative Medicine Sales (K Units) by Type (2022-2027)
Table 55. China Translational Regenerative Medicine Sales Share by Type (2022-2027)
Table 56. China Translational Regenerative Medicine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Translational Regenerative Medicine Revenue Share by Type (2022-2027)
Table 58. China Translational Regenerative Medicine Price (USD/Unit) by Type (2022-2027)
Table 59. China Translational Regenerative Medicine Sales (K Units) by Application (2016-2021)
Table 60. China Translational Regenerative Medicine Sales Share by Application (2016-2021)
Table 61. China Translational Regenerative Medicine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Translational Regenerative Medicine Price (USD/Unit) by Application (2016-2021)
Table 63. China Translational Regenerative Medicine Sales (K Units) by Application (2022-2027)
Table 64. China Translational Regenerative Medicine Sales Share by Application (2022-2027)
Table 65. China Translational Regenerative Medicine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Translational Regenerative Medicine Revenue Share by Application (2022-2027)
Table 67. China Translational Regenerative Medicine Price (USD/Unit) by Application (2022-2027)
Table 68. North America Translational Regenerative Medicine Sales by Country (2016-2021) & (K Units)
Table 69. North America Translational Regenerative Medicine Sales Market Share by Country (2016-2021)
Table 70. North America Translational Regenerative Medicine Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Translational Regenerative Medicine Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Translational Regenerative Medicine Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Translational Regenerative Medicine Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Translational Regenerative Medicine Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Translational Regenerative Medicine Revenue Market Share by Region (2016-2021)
Table 76. Europe Translational Regenerative Medicine Sales by Country (2016-2021) & (K Units)
Table 77. Europe Translational Regenerative Medicine Sales Market Share by Country (2016-2021)
Table 78. Europe Translational Regenerative Medicine Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Translational Regenerative Medicine Revenue Market Share by Country (2016-2021)
Table 80. Latin America Translational Regenerative Medicine Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Translational Regenerative Medicine Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Translational Regenerative Medicine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Translational Regenerative Medicine Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Translational Regenerative Medicine Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Translational Regenerative Medicine Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Translational Regenerative Medicine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Translational Regenerative Medicine Revenue Market Share by Country (2016-2021)
Table 88. Athersys Corporation Information
Table 89. Athersys Description and Business Overview
Table 90. Athersys Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Athersys Translational Regenerative Medicine Product
Table 92. Athersys Recent Development
Table 93. Avita Medical Corporation Information
Table 94. Avita Medical Description and Business Overview
Table 95. Avita Medical Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Avita Medical Product
Table 97. Avita Medical Recent Development
Table 98. AxoGen Corporation Information
Table 99. AxoGen Description and Business Overview
Table 100. AxoGen Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. AxoGen Product
Table 102. AxoGen Recent Development
Table 103. MEDIPOST Corporation Information
Table 104. MEDIPOST Description and Business Overview
Table 105. MEDIPOST Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. MEDIPOST Product
Table 107. MEDIPOST Recent Development
Table 108. NuVasive Corporation Information
Table 109. NuVasive Description and Business Overview
Table 110. NuVasive Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. NuVasive Product
Table 112. NuVasive Recent Development
Table 113. Astellas Pharma Corporation Information
Table 114. Astellas Pharma Description and Business Overview
Table 115. Astellas Pharma Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Astellas Pharma Product
Table 117. Astellas Pharma Recent Development
Table 118. Organogenesis Holdings Corporation Information
Table 119. Organogenesis Holdings Description and Business Overview
Table 120. Organogenesis Holdings Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Organogenesis Holdings Product
Table 122. Organogenesis Holdings Recent Development
Table 123. Osiris Therapeutics Corporation Information
Table 124. Osiris Therapeutics Description and Business Overview
Table 125. Osiris Therapeutics Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Osiris Therapeutics Product
Table 127. Osiris Therapeutics Recent Development
Table 128. Pharmicell Corporation Information
Table 129. Pharmicell Description and Business Overview
Table 130. Pharmicell Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Pharmicell Product
Table 132. Pharmicell Recent Development
Table 133. Regenerys Corporation Information
Table 134. Regenerys Description and Business Overview
Table 135. Regenerys Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Regenerys Product
Table 137. Regenerys Recent Development
Table 138. Takeda Pharmaceutical Corporation Information
Table 139. Takeda Pharmaceutical Description and Business Overview
Table 140. Takeda Pharmaceutical Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Takeda Pharmaceutical Product
Table 142. Takeda Pharmaceutical Recent Development
Table 143. uniQure Corporation Information
Table 144. uniQure Description and Business Overview
Table 145. uniQure Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. uniQure Product
Table 147. uniQure Recent Development
Table 148. Vericel Corporation Information
Table 149. Vericel Description and Business Overview
Table 150. Vericel Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. Vericel Product
Table 152. Vericel Recent Development
Table 153. Translational Regenerative Medicine Market Trends
Table 154. Translational Regenerative Medicine Market Drivers
Table 155. Translational Regenerative Medicine Market Challenges
Table 156. Translational Regenerative Medicine Market Restraints
Table 157. Translational Regenerative Medicine Customers List
Table 158. Translational Regenerative Medicine Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Translational Regenerative Medicine Product Picture
Figure 2. Global Translational Regenerative Medicine Sales Market Share by Type in 2020 & 2027
Figure 3. Stem Cell Therapy Product Picture
Figure 4. Tissue Engineering Product Picture
Figure 5. Gene Therapy Product Picture
Figure 6. Global Translational Regenerative Medicine Sales Market Share by Application in 2020 & 2027
Figure 7. Tissue Engineering Therapy
Figure 8. Wound Healing
Figure 9. Cartilage Repair
Figure 10. Other
Figure 11. Translational Regenerative Medicine Report Years Considered
Figure 12. Global Translational Regenerative Medicine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Translational Regenerative Medicine Market Size 2016-2027 (US$ Million)
Figure 14. Global Translational Regenerative Medicine Sales 2016-2027 (K Units)
Figure 15. Global Translational Regenerative Medicine Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Translational Regenerative Medicine Sales Market Share by Region (2016-2021)
Figure 17. Global Translational Regenerative Medicine Sales Market Share by Region in 2020
Figure 18. Global Translational Regenerative Medicine Revenue Market Share by Region (2016-2021)
Figure 19. Global Translational Regenerative Medicine Revenue Market Share by Region in 2020
Figure 20. Global Translational Regenerative Medicine Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Translational Regenerative Medicine Revenue in 2020
Figure 22. Translational Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Translational Regenerative Medicine Sales Market Share by Type (2016-2021)
Figure 24. Global Translational Regenerative Medicine Sales Market Share by Type in 2020
Figure 25. Global Translational Regenerative Medicine Revenue Market Share by Type (2016-2021)
Figure 26. Global Translational Regenerative Medicine Revenue Market Share by Type in 2020
Figure 27. Global Translational Regenerative Medicine Sales Market Share by Application (2016-2021)
Figure 28. Global Translational Regenerative Medicine Sales Market Share by Application in 2020
Figure 29. Global Translational Regenerative Medicine Revenue Market Share by Application (2016-2021)
Figure 30. Global Translational Regenerative Medicine Revenue Market Share by Application in 2020
Figure 31. China Translational Regenerative Medicine Sales Growth Rate 2016-2027 (K Units)
Figure 32. China Translational Regenerative Medicine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China Translational Regenerative Medicine Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest Translational Regenerative Medicine Players Market Share by Revenue in Translational Regenerative Medicine in 2020
Figure 35. China Translational Regenerative Medicine Revenue Share by Type (2016-2021)
Figure 36. China Translational Regenerative Medicine Revenue Growth Rate by Type in 2016 & 2020
Figure 37. China Translational Regenerative Medicine Revenue Share by Application (2016-2021)
Figure 38. China Translational Regenerative Medicine Revenue Growth Rate by Application in 2016 & 2020
Figur
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs